1. Home
  2. SILO vs STRR Comparison

SILO vs STRR Comparison

Compare SILO & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • STRR
  • Stock Information
  • Founded
  • SILO 2010
  • STRR 1985
  • Country
  • SILO United States
  • STRR United States
  • Employees
  • SILO N/A
  • STRR N/A
  • Industry
  • SILO Apparel
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SILO Consumer Discretionary
  • STRR Health Care
  • Exchange
  • SILO Nasdaq
  • STRR Nasdaq
  • Market Cap
  • SILO 4.3M
  • STRR 6.3M
  • IPO Year
  • SILO N/A
  • STRR N/A
  • Fundamental
  • Price
  • SILO $0.63
  • STRR $2.00
  • Analyst Decision
  • SILO
  • STRR Strong Buy
  • Analyst Count
  • SILO 0
  • STRR 1
  • Target Price
  • SILO N/A
  • STRR $5.00
  • AVG Volume (30 Days)
  • SILO 2.2M
  • STRR 21.4K
  • Earning Date
  • SILO 08-12-2025
  • STRR 08-12-2025
  • Dividend Yield
  • SILO N/A
  • STRR N/A
  • EPS Growth
  • SILO N/A
  • STRR N/A
  • EPS
  • SILO N/A
  • STRR N/A
  • Revenue
  • SILO $72,102.00
  • STRR $57,165,000.00
  • Revenue This Year
  • SILO $1.86
  • STRR $33.64
  • Revenue Next Year
  • SILO N/A
  • STRR $22.87
  • P/E Ratio
  • SILO N/A
  • STRR N/A
  • Revenue Growth
  • SILO N/A
  • STRR 34.33
  • 52 Week Low
  • SILO $0.41
  • STRR $1.72
  • 52 Week High
  • SILO $4.50
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • SILO 50.82
  • STRR 45.82
  • Support Level
  • SILO $0.60
  • STRR $1.95
  • Resistance Level
  • SILO $0.66
  • STRR $2.02
  • Average True Range (ATR)
  • SILO 0.04
  • STRR 0.07
  • MACD
  • SILO 0.02
  • STRR -0.00
  • Stochastic Oscillator
  • SILO 69.70
  • STRR 36.84

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

Share on Social Networks: